NCT06481397
- Conditions
- Pancreatic Ductal Adenocarcinoma (PDAC)
- Locations
-
- OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States
Clinical trial condition
Pancreatic Ductal Adenocarcinoma (PDAC)
Explore clinical trials studying Pancreatic Ductal Adenocarcinoma (PDAC). Study availability and eligibility vary by location and protocol.
68 public trials
39 recruiting studies
Pancreatic Ductal Adenocarcinoma (PDAC) trial results
NCT06720454
- Conditions
- Molecular Prognostic Model, Pancreatic Ductal Adenocarcinoma (PDAC), Regulons
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT06147154
- Conditions
- Pancreatic Ductal Adenocarcinoma (PDAC)
- Locations
-
- Qilu Hospital of Shandong University Jinan, Shandong, China
NCT03811652
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +37 more
- Locations
-
- Research Site Huntersville, North Carolina, United States
- Research Site Nashville, Tennessee, United States
- Research Site Toronto, Ontario, Canada
NCT03032913
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasm Metastasis, +8 more
- Locations
-
- Chu de Bordeaux Bordeaux, France
Active, Not Recruiting
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
- Locations
-
- University of California - Los Angeles - 300208353 Santa Monica, California, United States
- Providence Medical Foundation Santa Rosa, California, United States
- Georgetown University - Lombardi Comprehensive Cancer Center - 1134847 Washington D.C., District of Columbia, United States
- D&H Cancer Research Center Margate, Florida, United States
Active, Not Recruiting
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
NCT04083599
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +36 more
- Locations
-
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Cancer & Blood Specialty Clinic Los Alamitos, California, United States
- Moores Cancer Center at the UC San Diego Health San Diego, California, United States
- Yale University Cancer Center New Haven, Connecticut, United States
Active, Not Recruiting
HRS-4642 Combined With Nimotuzumab in the Treatment of Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma
NCT06773130
- Conditions
- Pancreatic Ductal Adenocarcinoma (PDAC)
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China